@article{13544adf3e484d02a99198eac7a90f48,
title = "Reduced excitatory amino acid transporter 1 and metabotropic glutamate receptor 5 expression in the cerebellum of fragile X mental retardation gene 1 premutation carriers with fragile X-associated tremor/ataxia syndrome",
abstract = "A premutation (PM) expansion (55-200 CGG) in the fragile X mental retardation gene 1 causes elevated messenger RNA and reduced fragile X mental retardation gene 1 protein. Young PM carriers can develop characteristic physical features and mild cognitive disabilities. In addition, individuals with PM, particularly male carriers, are at high risk to develop fragile X-associated tremor/ataxia syndrome (FXTAS) with aging. Human postmortem FXTAS brains show extensive white matter disease in the cerebellum and the presence of intranuclear inclusions throughout the brain, although their etiologic significance is unknown. In the current work, expression levels of the metabotropic glutamate (Glu) receptor 5 and the Glu transporter excitatory amino acid transporter 1, examined by reverse transcription polymerase chain reaction and western blot analyses, were found to be reduced in the postmortem cerebellum of PM carriers with FXTAS compared with age matched controls, with higher CGG repeat number having greater reductions in both proteins. These data suggests a dysregulation of Glu signaling in PM carriers, which would likely contribute to the development and severity of FXTAS.",
keywords = "EAAT1, EAAT2, FMR1, FMRP, FXTAS, Fragile X tremor/ataxia syndrome, Glu transporters, MGluR5, Premutation",
author = "Pretto, {Dalyir I.} and Madhur Kumar and Zhengyu Cao and Cunningham, {Christopher L.} and Blythe Durbin-Johnson and Lihong Qi and Robert Berman and Noctor, {Stephen C.} and Hagerman, {Randi J.} and Pessah, {Isaac N.} and Flora Tassone",
note = "Funding Information: This work was supported by the National Institute of Children Health and Human Development (NICHD) ( HD02274 and HD036071 ), the National Institute of Health (NIH) ( 1 P01 ES11269 and R01 ES 015359 ), the U.S. Environmental Protection Agency through the Science to Achieve Results (STAR) program ( R829388 and R833292 ), and the National Center for Advancing Translational Sciences (NCATS), NIH, ( UL1 TR000002 ). The authors wish to thank Dr Paul Hagerman for providing FXTAS brain tissues from the UC Davis brain repository (NIH HD040661) and for critical reading of the manuscript. We thank David Hampson for insightful discussion and sharing of mGluR1 and GLAST antibodies. We also thank Paul Ashwood for sharing mGluR1 and mGluR5 antibodies. Control human tissues were obtained from the Harvard Brain Tissue Resource Center, which is supported in part by PHS grant number R24 MH 068855; the NICHD Brain and Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore, Maryland supported by NICHD contract # NO 1-HD-4-3368 and NO1-HD-4-3383; and the Brain Endowment Bank, Dept. Neurology University of Miami Miller School of Medicine. TF designed the study, drafted the manuscript and participated in data analysis and interpretation of the results. DP ran experiments, participated in the design of the study, data analysis and interpretation of the results, and drafted the manuscript. MK ran experiments and participated in the writing of the manuscript. ZC ran experiments and participated in the analysis and interpretation of the results, and in the writing of the manuscript. CC ran experiments and participated in data analysis, interpretation of results, and in the writing of the manuscript. LH and BDJ performed the statistical analysis and contributed to the interpretation of data and drafting of the manuscript. SN critically revised the manuscript and participated in data analysis and interpretation of the results. RB critically revised the manuscript and participated in the interpretation of the results. RH performed clinical evaluations and participated in the writing and revision of the manuscript. IP participated in design of the experiments and critically revised the manuscript and participated in the data analysis and interpretation of the results. All authors read and approved the final manuscript.",
year = "2014",
month = may,
doi = "10.1016/j.neurobiolaging.2013.11.009",
language = "English (US)",
volume = "35",
pages = "1189--1197",
journal = "Neurobiology of aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",
number = "5",
}